FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040296817> ?p ?o ?g. }

• W2040296817 endingPage "483" @default.
• W2040296817 startingPage "475" @default.
• W2040296817 abstract "Targeted toxin-based therapeutics are hindered by poor intracellular uptake, limited stability and non-specific immune stimulation. To address these problems, ligand-targeted toxins in combination with low dose saponin mixtures have been adapted and tested in vivo in the past, however, undefined saponin raw mixtures are not suitable for use in clinical development. In the present work we therefore used a targeted toxin (Sap3-EGF, i.e. saporin fused to epidermal growth factor) in combination with a structurally defined isolated saponin m/z 1861 (SO-1861). In vitro evaluation confirmed a 6900-fold enhancement in the cytotoxic efficacy of Sap3-EGF against TSA-EGFR target cells. The required dose of the targeted toxin was appreciably reduced and there was a highly synergistic effect observed. An ex vivo hemolysis assay showed no or very less hemolysis up to 10 μg/mL of SO-1861. In the acute toxicity studies SO-1861 was found to be non-toxic up to a dose of 100 μg/treatment. The enzymes aspartate aminotransferase, alanine aminotransferase, and glutamate dehydrogenase did not show any statistically significant liver damage, which was further confirmed by histological examination. Additionally, creatinine was also similar to the control group thus ruling out damage to kidney. In vivo studies in a syngeneic BALB/c tumor model characterized by EGFR overexpression were done by applying 30 μg SO-1861 and 0.1 μg Sap3-EGF per treatment. A more than 90% reduction (p < 0.05) in the average tumor volume was observed by this combined therapy." @default.
• W2040296817 created "2016-06-24" @default.
• W2040296817 creator A5011101907 @default.
• W2040296817 creator A5016855923 @default.
• W2040296817 creator A5029863224 @default.
• W2040296817 creator A5035296579 @default.
• W2040296817 creator A5036407362 @default.
• W2040296817 creator A5043109000 @default.
• W2040296817 creator A5057440080 @default.
• W2040296817 creator A5068741789 @default.
• W2040296817 date "2012-12-28" @default.
• W2040296817 modified "2023-10-16" @default.
• W2040296817 title "Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: An evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice" @default.
• W2040296817 cites W1511216058 @default.
• W2040296817 cites W1538508587 @default.
• W2040296817 cites W155758270 @default.
• W2040296817 cites W1966119617 @default.
• W2040296817 cites W1970563206 @default.
• W2040296817 cites W1981156583 @default.
• W2040296817 cites W1982084720 @default.
• W2040296817 cites W1991320024 @default.
• W2040296817 cites W2005100061 @default.
• W2040296817 cites W2012785088 @default.
• W2040296817 cites W2014418809 @default.
• W2040296817 cites W2017757057 @default.
• W2040296817 cites W2022230966 @default.
• W2040296817 cites W2027895660 @default.
• W2040296817 cites W2031244563 @default.
• W2040296817 cites W2043845913 @default.
• W2040296817 cites W2065248620 @default.
• W2040296817 cites W2067479302 @default.
• W2040296817 cites W2073651499 @default.
• W2040296817 cites W2075930797 @default.
• W2040296817 cites W2091628702 @default.
• W2040296817 cites W2095116679 @default.
• W2040296817 cites W2104698079 @default.
• W2040296817 cites W2106787323 @default.
• W2040296817 cites W2120644636 @default.
• W2040296817 cites W2124900617 @default.
• W2040296817 cites W2129868701 @default.
• W2040296817 cites W2150432023 @default.
• W2040296817 cites W2314417484 @default.
• W2040296817 cites W2599055846 @default.
• W2040296817 doi "https://doi.org/10.1016/j.molonc.2012.12.004" @default.
• W2040296817 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5528469" @default.
• W2040296817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23298730" @default.
• W2040296817 hasPublicationYear "2012" @default.
• W2040296817 type Work @default.
• W2040296817 sameAs 2040296817 @default.
• W2040296817 citedByCount "30" @default.
• W2040296817 countsByYear W20402968172013 @default.
• W2040296817 countsByYear W20402968172014 @default.
• W2040296817 countsByYear W20402968172015 @default.
• W2040296817 countsByYear W20402968172016 @default.
• W2040296817 countsByYear W20402968172017 @default.
• W2040296817 countsByYear W20402968172018 @default.
• W2040296817 countsByYear W20402968172019 @default.
• W2040296817 countsByYear W20402968172020 @default.
• W2040296817 countsByYear W20402968172021 @default.
• W2040296817 countsByYear W20402968172022 @default.
• W2040296817 countsByYear W20402968172023 @default.
• W2040296817 crossrefType "journal-article" @default.
• W2040296817 hasAuthorship W2040296817A5011101907 @default.
• W2040296817 hasAuthorship W2040296817A5016855923 @default.
• W2040296817 hasAuthorship W2040296817A5029863224 @default.
• W2040296817 hasAuthorship W2040296817A5035296579 @default.
• W2040296817 hasAuthorship W2040296817A5036407362 @default.
• W2040296817 hasAuthorship W2040296817A5043109000 @default.
• W2040296817 hasAuthorship W2040296817A5057440080 @default.
• W2040296817 hasAuthorship W2040296817A5068741789 @default.
• W2040296817 hasBestOaLocation W20402968171 @default.
• W2040296817 hasConcept C126322002 @default.
• W2040296817 hasConcept C150903083 @default.
• W2040296817 hasConcept C170493617 @default.
• W2040296817 hasConcept C181199279 @default.
• W2040296817 hasConcept C185592680 @default.
• W2040296817 hasConcept C203014093 @default.
• W2040296817 hasConcept C207001950 @default.
• W2040296817 hasConcept C2776362946 @default.
• W2040296817 hasConcept C2777318727 @default.
• W2040296817 hasConcept C2779902561 @default.
• W2040296817 hasConcept C29730261 @default.
• W2040296817 hasConcept C55493867 @default.
• W2040296817 hasConcept C71924100 @default.
• W2040296817 hasConcept C86803240 @default.
• W2040296817 hasConcept C98274493 @default.
• W2040296817 hasConceptScore W2040296817C126322002 @default.
• W2040296817 hasConceptScore W2040296817C150903083 @default.
• W2040296817 hasConceptScore W2040296817C170493617 @default.
• W2040296817 hasConceptScore W2040296817C181199279 @default.
• W2040296817 hasConceptScore W2040296817C185592680 @default.
• W2040296817 hasConceptScore W2040296817C203014093 @default.
• W2040296817 hasConceptScore W2040296817C207001950 @default.
• W2040296817 hasConceptScore W2040296817C2776362946 @default.
• W2040296817 hasConceptScore W2040296817C2777318727 @default.
• W2040296817 hasConceptScore W2040296817C2779902561 @default.
• W2040296817 hasConceptScore W2040296817C29730261 @default.
• W2040296817 hasConceptScore W2040296817C55493867 @default.

• next